文献速递青光眼角膜与眼表疾病

继发于虹膜角膜内皮综合征的青光眼实现内房水引流:穿透性房角成形术一年结果

Achieving Inner Aqueous Drain in Glaucoma Secondary to Iridocorneal Endothelial Syndrome: One Year Results of Penetrating Canaloplasty.
PubMed 文献 · Am J Ophthalmol · 2022-07-21

前瞻性非对照临床研究纳入35眼继发于虹膜角膜内皮综合征的青光眼,行穿透性房角成形术,29眼(82.9%)完成360°导管置入并手术,术后12个月平均眼压从术前39.5±11.8 mmHg降至16.6±5.3 mmHg(P<.001),降眼压药物从2.9±1.0种减至0.2±0.6种(P<.001),结论认为该术式可重建内房水流出并提供新选择。

要点

  • 29眼(82.9%)完成360°导管置入并成功行穿透性房角成形术。
  • 术后12个月平均眼压16.6±5.3 mmHg,较术前39.5±11.8 mmHg下降(P<.001)。
  • 术后12个月降眼压药物0.2±0.6种,较术前2.9±1.0种减少(P<.001)。

核心结论

  • 穿透性房角成形术可重建虹膜角膜内皮综合征眼的内房水流出,眼压控制成功率可接受且并发症少,为继发于虹膜角膜内皮综合征的青光眼提供新选择。

研究设计与样本

  • 前瞻性非对照临床研究,纳入2018年1月至2020年4月间35例患者的35眼继发于虹膜角膜内皮综合征且药物无法控制眼压的青光眼,行穿透性房角成形术,术后1周、1、3、6、12个月及此后每半年随访。

主要发现

  • 29眼(82.9%)完成360°导管置入并成功接受穿透性房角成形术。
  • 术后12个月,24眼(82.8%)达到条件成功,22眼(75.9%)达到完全成功。
  • 平均眼压从术前39.5±11.8 mmHg(使用2.9±1.0种降眼压药物)降至术后12个月16.6±5.3 mmHg(P<.001),降眼压药物减至0.2±0.6种(P<.001)。
  • 术后1周和1个月随访最常见的早期并发症为前房积血(37.9%)、一过性低眼压(34.5%)和一过性术后眼压升高(≥30 mmHg,17.9%)。
  • 术后1个月及以后,所有治疗眼在手术象限均未见明显滤过泡。

关键数值与推荐

  • 手术成功定义为眼压≥5 mmHg且≤21 mmHg,不使用降眼压药物为完全成功,使用或不使用降眼压药物为条件成功。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSES: To report the efficacy of a bleb-independent penetrating canaloplasty in the management of glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE). DESIGN: Prospective, non-comparative clinical study. METHODS: Penetrating canaloplasty was performed on 35 eyes from 35 patients with GS-ICE and medically uncontrolled intraocular pressure (IOP) between January 2018 and April 2020. Patients were followed up at 1 week, months 1, 3, 6, 12 postoperatively, and semi-annually thereafter. The IOP, anti-glaucoma medication, and surgery-related complications were recorded. Surgical success was defined as IOP ≥ 5 mmHg and ≤ 21 mmHg without (complete success) or with/without (qualified success) IOP-lowering medication. RESULTS: A total of 29 eyes (82.9%) had 360° catheterization and successfully received penetrating canaloplasty. Of these eyes, 24 (82.8%) achieved qualified success and 22 (75.9%) achieved qualified success at 12 months after surgery. The mean IOP decreased from 39.5 ± 11.8 mmHg on 2.9 ± 1.0 medications before surgery to 16.6 ± 5.3 mmHg (P < .001) on 0.2 ± 0.6 medications (P < .001) at 12 months postoperatively, respectively. Hyphema (37.9%), transient hypotony (34.5%), and transient postoperative IOP elevation (≥ 30 mmHg, 17.9%) were the most commonly observed early complications at the 1 week and 1 month visits. From 1 month and beyond, all treated eyes showed no obvious bleb at the operation quadrant. CONCLUSIONS: Penetrating canaloplasty rescued the inner aqueous outflow in ICE eyes and demonstrated acceptable success in IOP control with few complications, providing a new option for the management of GS-ICE.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Deng Y, Zhang S, Ye W, et al. Achieving Inner Aqueous Drain in Glaucoma Secondary to Iridocorneal Endothelial Syndrome: One Year Results of Penetrating Canaloplasty. Am J Ophthalmol. 2022. PMID: 35870489. doi:10.1016/j.ajo.2022.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。